General Information
Version
6.9
Revision date
2025-01-20
Product name
Flucycloxuron
CAS No.
113036-88-7
REACH No
A
Emergency telephone
+41 43-508-2011, +41 44-251-5151
Icons in SDS
Company Information
company name
Sigma-Aldrich Chemie GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
technischerservice@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H413
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Eye irritation, (Category 2) H319: Causes serious eye irritation. Long-term (chronic) aquatic H413: May cause long lasting harmful hazard, (Category 4) effects to aquatic life.
Signal word
Warning Warning
Hazard statements
H319 Causes serious eye irritation. H413 May cause long lasting harmful effects to aquatic life. H413 May cause long lasting harmful effects to aquatic life.
Precautionary statements
P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention. P501 Dispose of contents/ container to an approved waste disposal plant. none
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.